TREM2 and systemic sclerosis: Overall, these data illustrated the dynamic and heterogenous features of macrophages and identified a therapeutic potentiality of TREM2-dependent macrophages in skin fibrosis, which might provide an opportunity for targeting TREM2 and a novel effective strategy to develop advanced cell therapies for refractory fibrosis of SSc.